RETACRIT

NDC 0069-1309 · Pfizer Laboratories Div Pfizer Inc

Generic nameepoetin alfa-epbx

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)EPOETIN

Strength40000 [iU]/mL

Pharmacologic classErythropoiesis-stimulating Agent [EPC], Erythropoietin [CS], Increased Erythroid Cell Production [PE]

Marketing categoryBLA

Packages

0069-1309-04 — 4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01)

Q5105 — Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units Medicare Part B payment limit (ASP + 6%): $0.80

Q5106 — Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units Medicare Part B payment limit (ASP + 6%): $7.97

FDA lists these products with the same active ingredient.

0069-1305 — epoetin alfa-epbx, 0069-1306 — epoetin alfa-epbx, 0069-1307 — epoetin alfa-epbx, 0069-1308 — epoetin alfa-epbx, 0069-1311 — epoetin alfa-epbx, 0069-1318 — epoetin alfa-epbx, 55513-126 — epoetin alfa, 55513-144 — epoetin alfa, 55513-148 — epoetin alfa, 55513-267 — epoetin alfa, 55513-283 — epoetin alfa, 55513-478 — epoetin alfa, 59353-002 — epoetin alfa-epbx, 59353-003 — epoetin alfa-epbx, 59353-004 — epoetin alfa-epbx, 59353-010 — epoetin alfa-epbx, 59353-120 — epoetin alfa-epbx, 59353-220 — epoetin alfa-epbx, 59676-302 — Erythropoietin, 59676-303 — Erythropoietin, +5 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.